Co-administration with TAMs remarkably boosted ID8/Ubr5−/− tumor growth, ascites fluid accumulation, tumor proliferation, and spheroid formation to the levels seen with the ID8/GFP tumor (Fig. 3a–c and Supplementary Fig. 5b–d). Here, UBR5 is linked to neoplasm.